Ghana braces for possible first Marburg virus outbreak
by Alex Whiting HPV prevention and vaccines help reduce the number of women dying from cervical cancer but new portable screening tools and new types of laboratory tests will improve early diagnosis and treatment of the disease. New advances in cervical cancer screening — the fourth most common cancer among women — have the potential to save many women’s lives, their developers say. While outcomes for women with cervical cancer have improved overall in recent years, the mortality rate from the disease is still too high. Despite the fact that cervical cancer is highly treatable if diagnosed early enough, more than 340,000 women died from the disease in 2020. The majority of deaths occur in low- and middle-income countries where women often have limited access to screening services, according to the World Health Organization. Even when women are tested, there may be a delay of several months before they get the results and, if they test positive, another delay before they receive treatm